Susquehanna International Group
CODX

Susquehanna International Group’s Co-Diagnostics CODX Stock Holding History

Susquehanna International Group’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-440
Closed -$2.23K – 13280
2025
Q4 		$2.23K Sell
440
-620
-58% -$6.75K ﹤0.01% 12128
2025
Q3 		$10.8K Buy
+1,060
New +$9.86K ﹤0.01% 12091
2025
Q1 		– Sell
-3,350
Closed -$75.4K – 12585
2024
Q4 		$75.4K Buy
3,350
+1,797
+116% +$56.8K ﹤0.01% 11500
2024
Q3 		$58.3K Sell
1,553
-2,387
-61% -$91.6K ﹤0.01% 11321
2024
Q2 		$148K Buy
3,940
+3,407
+639% +$124K ﹤0.01% 10708
2024
Q1 		$17.9K Buy
533
+26
+5% +$942 ﹤0.01% 11839
2023
Q4 		$20.2K Sell
507
-100
-16% -$3.52K ﹤0.01% 11974
2023
Q3 		$19.3K Buy
607
+30
+5% +$1.13K ﹤0.01% 11610
2023
Q2 		$19.2K Buy
577
+87
+18% +$3.33K ﹤0.01% 11647
2023
Q1 		$21.8K Sell
490
-3,017
-86% -$242K ﹤0.01% 12023
2022
Q4 		$265K Sell
3,507
-8,020
-70% -$751K ﹤0.01% 9403
2022
Q3 		$1.11M Buy
11,527
+2,290
+25% +$320K ﹤0.01% 6362
2022
Q2 		$1.55M Buy
9,237
+47
+0.5% +$7.15K ﹤0.01% 5437
2022
Q1 		$1.7M Sell
9,190
-3,407
-27% -$705K ﹤0.01% 5833
2021
Q4 		$3.38M Buy
12,597
+714
+6% +$187K ﹤0.01% 4453
2021
Q3 		$3.47M Buy
11,883
+380
+3% +$111K ﹤0.01% 4647
2021
Q2 		$2.85M Sell
11,503
-4,870
-30% -$1.25M ﹤0.01% 5140
2021
Q1 		$4.69M Buy
16,373
+3,850
+31% +$1.54M ﹤0.01% 4026
2020
Q4 		$3.49M Sell
12,523
-2,120
-14% -$785K ﹤0.01% 4050
2020
Q3 		$5.97M Buy
14,643
+2,466
+20% +$1.27M ﹤0.01% 2826
2020
Q2 		$7.07M Buy
12,177
+11,257
+1,224% +$5.14M ﹤0.01% 2568
2020
Q1 		$210K Buy
+920
New +$160K ﹤0.01% 8594

Other funds holding CODX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAG
Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group's CODX Position: Q2 2026 in Review

Susquehanna International Group opened a new position in Co-Diagnostics (CODX) in Q2 2026: 31,239 shares worth $96.8K. The stake represents ﹤0.01% of the portfolio and ranks #12518 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in CODX as recently as Q4 2025.

Susquehanna International Group first reported a position in CODX in Q1 2020 and has held it in 25 quarters since. The position peaked at $4.13M in Q3 2021. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

  • Susquehanna International Group held 31,239 shares of Co-Diagnostics worth $96.8K as of Q2 2026.
  • Co-Diagnostics was a new Susquehanna International Group position in Q2 2026.
  • Co-Diagnostics made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #12518 holding.
  • Susquehanna International Group first reported a position in Co-Diagnostics in Q1 2020 and has held it in 25 quarters since.
  • Susquehanna International Group's Co-Diagnostics position peaked at $4.13M in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.